Silver Book

Silver Book Fact

Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually

Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.

Roberts, Rebecca R., Bala Hota, Ibrar Ahmad, R. Douglas Scott, Susan D. Foster, Fauzia Abbasi, Shari Schabowski, Linda M. Kampe, Ginerva G. Ciavarella, Mark Supino, Jeremy Naples, Ralph Cordell, Stuart B. Levy, and Robert A. Weinstein. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship. Clin Infect Dis. 2009; 49(8): 1175-84. http://cid.oxfordjournals.org/content/49/8/1175.full

Reference

Title
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship
Publication
Clin Infect Dis
Publication Date
2009
Authors
Roberts, Rebecca R., Bala Hota, Ibrar Ahmad, R. Douglas Scott, Susan D. Foster, Fauzia Abbasi, Shari Schabowski, Linda M. Kampe, Ginerva G. Ciavarella, Mark Supino, Jeremy Naples, Ralph Cordell, Stuart B. Levy, and Robert A. Weinstein
Volume & Issue
Volume 49, Issue 8
Pages
1175-84
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Publications

Healthcare-Associated Infections Factsheet

 https://www.silverbook.org/wp-content/uploads/2015/06/Screen-Shot-2015-06-30-at-3.02.28-PM.png Thumbnail

Related Facts

  • Antibacterial resistant pathogens responsible for most of 99,000 HAI related deaths
    The majority of the 99,000 patients who die from healthcare-associated infections each year, are due to antibacterial-resistant pathogens.  
  • Primary sources of HAIs
    Around 2/3 of all HAIs are central-line associated bloodstream infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia. Surgical site infections and Clostridium difficile (C. difficile) are also common HAIs.  
  • Risk of HAIs from hospitalization increases with age
    Hospitalized elderly patients are 2 – 5 times more likely to develop a healthcare-associated infection than younger patients.  
  • Drug-resistant infections increase length & cost of hospital stays
    Drug-resistant infections increase the length of hospital stays by more than 23% and the cost by close to 30%.  
  • Sepsis in hospitalized patients
    Hospitalized patients with sepsis who survived to 31 days experienced a 16.2% absolute increase in late mortality.